Specialized Therapies | HIV

Press Releases and Company Announcements

Recent News

Sep 25, 2025

Theratechnologies Announces Completion of Acquisition by Future Pak

Learn More
Sep 16, 2025

Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak

Learn More
Sep 12, 2025

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak

Learn More
Sep 05, 2025

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

Learn More

Pipeline & Medicines

Product Pipeline & Portfolio

Theratechnologies develops and commercializes innovative therapies. The Company currently commercializes two products in the field of HIV. Trogarzo® and EGRIFTA SV®/WR™ are approved in the United States. 

EgriftaSV
Trogarzo
Learn About HIV
Learn About Trogarzo®
Learn About EGRIFTA SV®/WR™
 
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Marketed